JohnDoe wrote:Will liposomal vit C count towards bowel tolerance?
If you get loose stools with 40 grams of AA, will you then also get loose stools with f.ex. (Liposomal vit C eqivivalent 10 gram AA) + (30 grams AA), or with (Liposomal vit C equivivalent to 20 grams) + (20 grams AA)?
will the lip. vit C NOT count towards BT, and you will still need 40 grams of AA no matter how much lipo you take in addtion?
Good questions. Experimented years ago first with bowel-tolerance of regular AA, and then by adding in self-made liposomal. With AA alone daily bowel-tolerance was reached at 50g per day, while with liposomal-encapsulated I could tolerate somewhat higher. About 70 g a day, if I remember it right now. Which would mean liposomal increases bowel-tolerance somewhat, and if it would be additive, only somewhat.
However, there have been case-studies with further hinds, but because it tested only about 2 subjects comparing serum levels at different doses, but not by adding them up in one person, it doesn't again answer your question conclusively:https://www.longecity.org/forum/topic/6 ... ntry632177
Even the highest dose tested in these case studies, 36g, caused similar plasma curves for both, liposomal and regular AA. And in this case for both subjects bowel-tolerance was exceeded.
With this high
dose, both subjects exceeded their bowel tolerance, leading to diarrhoea. This
intolerance presumably arose from the high intake of phospholipid, without food
buffering, in fasting individuals. However, our observations using hourly doses suggest
that daily intakes of this magnitude are tolerable without bowel effects, as long as the
dose is spread throughout the day.
So there is an individual bowel-tolerance for phospholipids, as there is for ascrobic acid. Since they are probably mediated by different mechanisms, probably only somewhat additive. As in my experience.
How much exactly in your case could only be known if you tested bowel-tolerance first for AA in yourself. Next with liposomes. Than in varying degrees of mixtures.